Page last updated: 2024-09-03

3-quinuclidinyl-4-iodobenzilate and fluorodeoxyglucose f18

3-quinuclidinyl-4-iodobenzilate has been researched along with fluorodeoxyglucose f18 in 1 studies

Compound Research Comparison

Studies
(3-quinuclidinyl-4-iodobenzilate)
Trials
(3-quinuclidinyl-4-iodobenzilate)
Recent Studies (post-2010)
(3-quinuclidinyl-4-iodobenzilate)
Studies
(fluorodeoxyglucose f18)
Trials
(fluorodeoxyglucose f18)
Recent Studies (post-2010) (fluorodeoxyglucose f18)
374034,7712,16020,111

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR1

Other Studies

1 other study(ies) available for 3-quinuclidinyl-4-iodobenzilate and fluorodeoxyglucose f18

ArticleYear
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    The Journal of neuropsychiatry and clinical neurosciences, 1992,Summer, Volume: 4, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1992